AI-generated summary
The authors reviewed FDA-approved and upcoming treatments for dry eye disease using PubMed, the FDA website, ClinicalTrials.gov and public data. They describe several approved drug formulations and devices, plus many newer agents still under evaluation. The authors state that new treatments and delivery systems seem promising, while noting that the disease's pathophysiology needs further understanding.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract does not report the number of studies reviewed or the strength of evidence for the newer treatments.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.